Differences in peptic ulcer between East and West

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 1, 2000, Pages 41-52

  Lam, Shiu Kum ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTACID AGENT; BISMUTH; CIMETIDINE; CLARITHROMYCIN; DEBRISOQUINE; LANSOPRAZOLE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PENTAGASTRIN; PHENYTOIN; PLACEBO; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

CLINICAL TRIAL; DUODENUM ULCER; EASTERN HEMISPHERE; ENVIRONMENTAL FACTOR; ERADICATION THERAPY; FEMALE; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEREDITY; HUMAN; MALE; ONSET AGE; PEPTIC ULCER; PREVALENCE; RACE DIFFERENCE; REVIEW; SEASONAL VARIATION; SEX RATIO; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; STOMACH ULCER; ULCER HEALING; WESTERN HEMISPHERE;

EID: 0034018979     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0058     Document Type: Article

References (81)

1. ICH Steering Committee, Ethnic Factors in the Acceptability of Foreign Clinical Data. Harmonised Tripartite Guideline, 1, 14, 1998.
2. Tien H S, Zhi X H, Wu Z B, Sung G F. Studies on the pathological changes and the cause of death. Wu Z B. Studies of an Ancient Corpse of the Western Han Dynasty Unearthed from Tomb No. 168 on the Phoenix Hill at Jiangling. 1982;196-219 Cultural Relics Publishing House, Beijing.
3. Cruveilhier J. Maladies de l'estomac, de l'Anatomie Pathologique du Corps Humain. 1835;Baillière, Paris.
4. Grossman M I. Peptic ulcer: definition and epidemiology. Rotter J I, Samloff I M, Rimoin D L. The Genetics and Heterogeneity of Common Gastrointestinal Disorders. 1980;21-24 Academic Press, New York.
5. Sung J L, Wang T H, Lu T H. Epidemiological study on peptic ulcer and gastric cancer in the Chinese. Rendic Gastroenterology. 6:1974;111-115.
6. Langman M JS. Peptic ulcer. The Epidemiology of Chronic Digestive Disease. 1979;Year Book Medical Publisher, Chicago. p. 9-39.
7. Lam S K, Byth K, Ng M MT. Perforated peptic ulcer in Hong Kong and New South Wales. Journal of Gastroenterology and Hepatology. 7:1992;508-511.
8. Laine L, Hopkins R J, Girardi L S. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. American Journal of Gastroenterology. 93:1998;1409-1415.
9. Maher W, Jyotheeswaran S, Potter G. An epidemiological study of peptic ulcer disease patients in greater Rochester, New York. Gastroenterology. 112:1997;A206.
10. Lam S K, Ching C K, Lai K C. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double-blind placebo-controlled study. Gut. 41:1997;43-48.
11. Collier D StJ, Pain J A. Non-steroidal anti-inflammatory drugs and perforation. Gut. 26:1985;359-363.
12. Hui W M, Lam S K, Shiu L P, Ng M MT. Semi-quantitative study of negative social events, stress and incidence of perforated peptic ulcer in Hong Kong over 24 years. Gastroenterology. 98:1990;A61.
13. Hollander D, Tarnawski A. Dietary essential fatty acids and the decline in peptic ulcer disease - a hypothesis. Gut. 27:1986;239-242.
14. Doll R, Jones F A, Bukatzsch M M. Occupational Factors in the Aetiology of Gastric and Duodenal Ulcers with an Estimate of their Incidence in the General Population. 1951.
15. Bonnevie O. The incidence of duodenal ulcer in Copenhagen County. Scandinavian Journal of Gastroenterology. 10:1975;385-393.
16. Kurata J H, Haile B M. Epidemiology of peptic ulcer disease. Clinics in Gastroenterology. 13:1984;289-305.
17. Kawai K, Shirakawa K, Misaki F. Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology. 96:1989;581-585.
18. Hugh T B, Coleman M J, McNamara M E. Epidemiology of peptic ulcer in Australia. A study based on government statistics in four states. Medical Journal of Australia. 141:1984;81-85.
19. Tovey F. Peptic ulcer in India and Bangladesh. Gut. 20:1979;329-347.
20. Moshal M G, Spitaels J M, Robbs J V. Eight-year experience with 3392 endoscopically proven duodenal ulcers in Durban, 1972-79. Gut. 22:1981;327-331.
21. Wong B CY, Ching C K, Lam S K. Differential north to south gastric cancer-duodenal ulcer gradient in China. Journal of Gastroenterology and Hepatology. 13:1998;1050-1057.
22. Tovey F I. Diet and duodenal ulcer. Journal of Gastroenterology and Hepatology. 9:1994;177-185.
23. Ching C K, Lam S K, Chen B W. North-south gastric cancer and duodenal ulcer disease gradients in China. Gastroenterology. 108:1995;A8.
24. Sasaki H, Nagulesparan M, Samloff I M. Low acid output in Pima Indians. A possible cause for the rarity of duodenal ulcer in this population. Digestive Diseases and Sciences. 9:1984;785-789.
25. Sievers M L, Marquis J R. Duodenal ulcer among South-western American Indians. Gastroenterology. 42:1962;566-569.
26. May J M. Report on the geography of peptic ulcers. Schweizer Zeitschrift für Pathologie und Bakteriologie. 21:1985;169-209.
27. Kouwenaar W. Gastric and duodenal ulcers in Sumatra's east coast and their pathogenesis. Transaction of the Eighth Congress Far East, Ass Trop Med. 1:1930;587-597.
28. Bateson E M. Duodenal ulcer - does it exist in Australian Aborigines? Australian and New Zealand Journal of Medicine. 6:1976;545-547.
29. Raper A B. The incidence of peptic ulceration in some African tribal groups. Transactions of the Royal Society of Tropical Medicine and Hygiene. 52:1958;535-546.
30. Kang, J, Y, Peptic Ulcer Disease in Singapore with Particular Reference to Racial Differences, 1988.
31. Kurata J H, Haile B M. Racial differences in peptic ulcer disease: fact or myth? Gastroenterology. 83:1982;166-172.
32. Ivy A C. The problem of peptic ulcer. Journal of the American Medical Association. 132:1946;1053-1059.
33. Boles R S, Westerman M P. Seasonal incidence and precipitating causes of hemorrhage from peptic ulcer. Journal of the American Medical Association. 156:1954;1379-1383.
34. Ahmed S Z, Levine M, Finkbiner R. The seasonal incidence of complications of peptic ulcer. Annals of Internal Medicine. 59:1963;165-171.
35. Gibinski K, Rybicka J, Nowak A, Czarnecka K. Seasonal occurrence of abdominal pain and endoscopic findings in patients with gastric and duodenal ulcer disease. Scandinavian Journal of Gastroenterology. 17:1982;481-485.
36. Hui W M, Lam S K. Monthly variation in duodenal ulcer frequency and maximal acid output. Journal of Gastroenterology and Hepatology. 3:1988;457-463.
37. Susser M, Stein Z. Civilization and peptic ulcer. Lancet. 1:1962;115-119.
38. Kellow J E, Tao Z, Piper D W. Ventilatory function in chronic peptic ulcer. A controlled study of ventilatory function in patients with gastric and duodenal ulcer. Gastroenterology. 91:1986;590-595.
39. Watkinson G. The incidence of chronic peptic ulcer found at necropsy. Gut. 1:1960;14-31.
40. Elashoff J D, Grossman M T. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978. Gastroenterology. 78:1980;280-285.
41. Bernersen B, Johnsen R, Straume B. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut. 31:1990;989-992.
42. Lam S K, Ong G B. Duodenal ulcers: early and late onset. Gut. 17:1976;169-179.
43. Jayaraj A P, Tovey F I, Clark C G. Possible dietary protective factors in relation to the distribution of duodenal ulcer in India and Bangladesh. Gut. 21:1980;1068-1076.
44. Tovey F I, Tunstall M. Duodenal ulcer in black populations in Africa South of the Sahara. Gut. 16:1975;564-576.
45. Segal I, Dubb A A, Tim L O. Duodenal ulcer and working-class mobility in an African population in South Africa. British Medical Journal. 1:1978;115-119.
46. Koo J, Ngan Y K, Lam S K. Trends in hospital admission, perforation and mortality of peptic ulcer in Hong Kong from 1970 to 1980. Gastroenterology. 84:1983;1558-1562.
47. Lam S K, Koo J, Sircus W. Early- and late-onset duodenal ulcers in Chinese and Scots. Scandinavian Journal of Gastroenterology. 18:1983;651-658.
48. Bernersen B, Johnsen R, Straume B. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut. 31:1990;989-992.
49. Linstrom C G. Gastric and duodenal peptic ulcer disease in a well-defined population: a prospective necropsy study in Malmo, Sweden. Scandinavian Journal of Gastroenterology. 13:1978;139-143.
50. Kurata J H, Haile B M, Elashoff J D. Sex differences in peptic ulcer disease. Gastroenterology. 88:1985;96-100.
51. Billington B P. Observations from New South Wales on changing incidence of gastric ulcer in Australia. Gut. 6:1956;121-133.
52. Moshal M G. Ethnic differences in duodenal ulceration. II: 3392 patients in Durban (1972-1979). Rotter J I, Samloff I M, Rimoin D L. The Genetics and Heterogeneity of Common Gastrointestinal Disorders. 1980;101-110 Academic Press, New York.
53. Elashoff J D, Grossman M T. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978. Gastroenterology. 78:1980;280-285.
54. Hassan M, Shah M D, Ali K. Peptic ulcer in Bangladesh: an endoscopic survey. Gut. 25:1985;A1117.
55. Sung J L, Wang T H, Lu T H. Epidemiological study on peptic ulcer and gastric cancer in the Chinese. Rendic Gastroenterology. 6:1974;111-115.
56. Kang J Y. Mortality from peptic ulcer in Singapore 1938-1980. Singapore Medical Journal. 24:1983;333-336.
57. Zhao X C, Li J M, Peng W C. Observations on peptic ulcer in Shan Dong, China. Journal of Gastroenterology and Hepatology. 3:1988;345-348.
58. Ostensen H, Gudmundsen T E, Bolz K D. The incidence of gastric ulcer and duodenal ulcer in North Norway: a prospective epidemiological study. Scandinavian Journal of Gastroenterology. 20:1985;189-192.
59. Iwasake M. Nation-wide tabulation of results in gastric mass survey. Stomach and Intestine. 6:1971;745-750.
60. McIntosh J H, Byth K, Piper D W. Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut. 26:1985;789-798.
61. Duggan J M, Dobson A J, Johnson H. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut. 27:1986;929-933.
62. Poynard T, Pignon J P. Acute Treatment of Duodenal Ulcer: Analysis of 293 Randomized Clinical Trials. 1989;John Libbey, Montrouge.
63. Sontag S, Graham D Y, Belsito A. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. New England Journal of Medicine. 311:1984;689-693.
64. Hosking S W, Ling T KW, Chung S CS. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 343:1994;508-510.
65. Lam S K, Hui W M, Ching C K. Epidemiology, pathogenesis and etiology of peptic ulcer. Haubrich W S, Schaffner F, Berk J E. Bockus Gastroenterology. 1994;700-748 WB Saunders, Philadelphia.
66. Ho J, Lui I, Hui W M. A study of the correlation of duodenal-ulcer healing with campylobacter-like organisms. Journal of Gastroenterology and Hepatology. 1:1986;69-74.
67. Doll R, Pygott F. Factors influencing the rate of healing of gastric ulcers. Lancet. 1:1952;171.
68. Doll R, Price A V, Pygott F, Sanderson P H. Continuous intragastric milk drip in treatment of complicated gastric ulcer. Lancet. 1:1956;70.
69. Rydning A, Berstad A. Dietary aspects of peptic ulcer disease. Scandinavian Journal of Gastroenterology. 20:1985;29-33.
70. Vakil B J, Mulekar A M. Studies with the maximal histamine test. Gut. 7:1965;364-371.
71. Guo F L, Chen G Z, Liu S Q. The effects of smoking and nicotine on the parietal cell mass of human beings and rats. Journal of Gastroenterology and Hepatology. 1:1986;45-54.
72. Lam S K, Hasan M, Sircus W. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut. 21:1981;324-328.
73. Lam S K, Koo J. Accurate prediction of duodenal-ulcer healing rate by discriminant analysis. Gastroenterology. 85:1983;403-412.
74. Lam S K. Antacids: past, present and future. Clinics in Gastroenterology. 2:1988;641-654.
75. Hui W M, Lam S K, Lau W Y. Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse - a randomized double-blind study with weekly endoscopic assessment. Journal of Gastroenterology and Hepatology. 4:1989;35-43.
76. Goh K L, Boonyapisit S, Lai K H. Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study. Journal of Gastroenterology and Hepatology. 10:1995;92-97.
77. van der Hulst R WM, van der Ende A, Homan A. Gut. 42:1998;166-169.
78. Wang, W, H, Wong, B, CY, Lam, S, K, Pooled analysis of Helicobacter pylori eradication regimes in Asia, 1999.
79. Lam S K, Wong C Y. Prospective double-blind randomized placebo-controlled study comparing two lansoprazole-based triple therapy and one dual therapy for Helicobacter pylori -related duodenal ulcer: an Asian multicenter study. Gastroenterology. 116:1999;G1562.
80. Card W I, Marks I N. The relationship between the acid output of the stomach following 'maximal' histamine stimulation and the parietal cell mass. Clinical Science. 19:1960;47-63.
81. Cheng F CY, Lam S K, Ong G B. Maximal acid output to graded doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer. Gut. 18:1977;827-832.